학술논문

Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma
Document Type
Article
Source
In: Clinical Pharmacology in Drug Development. (Clinical Pharmacology in Drug Development, September 2022, 11(9):1099-1109)
Subject
Language
English
ISSN
21607648
2160763X